Biomadison, Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Biomadison, Inc. opposed by its competitors

Patent:
Grant Date:
Apr 3, 2024
Title:
Botulinum Toxin Assay With Improved Sensitivity
Oppositions:
1
Patent:
Grant Date:
Aug 16, 2023
Title:
Botulinum Toxin Assay With Improved Sensitivity
Oppositions:
1
Patent:
Grant Date:
May 16, 2018
Title:
Methods And Compounds For Increasing Sensitivity Of Botulinum Assays
Oppositions:
1

Competitors of Biomadison, Inc.

MERZ PHARMA GMBH & CO. KGAA

Want to track Biomadison, Inc.?

Feel free to send us a message here and we will get back to you